Dr J Mark Treherne
Mark was formerly at Pfizer in the UK, until 1997, when he set up Cambridge Drug Discovery as Chief Executive, which was sold to BioFocus PLC in 2001 for £28 million.
Mark has over 20 years' experience in drug discovery and development and has raised over £100 million and served on the boards of ten private and public companies.
Mark obtained his PhD from Cambridge University funded by Merck.
Mark's CV can be downloaded from our Downloads section of the website. (Basic registration required)